Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma
نویسندگان
چکیده
منابع مشابه
Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
BACKGROUND: Allergic subjects produce relatively low amounts of IFN-gamma, a pleiotropic Th-1 cytokine that downregulates Th2-associated airway inflammation and hyperresponsiveness (AHR), the hallmarks of allergic asthma. Adenovirus-mediated IFN-gamma gene transfer reduces AHR, Th2 cytokine levels and lung inflammation in mice, but its use would be limited by the frequency of gene delivery requ...
متن کاملThe rationale for treating allergic asthma with anti-IgE
An estimated two-thirds of asthma is allergic and .50% of severe asthma has an allergic component. An increased immunoglobulin (Ig)E production in response to environmental allergens (atopy) is the strongest detectable predisposing factor for the development of asthma, particularly when sensitisation occurs early in life. IgE binds to high-affinity receptors (FceRI) on effector cells, such as m...
متن کاملRe: treating asthma and comorbid allergic rhinitis in pregnancy.
Women with severe or uncontrolled asthma are at higher risk for pregnancy complications and adverse fetal outcomes than women with well-controlled asthma. Recent evidence-based guidelines have concluded that it is safer for pregnant women with asthma to be treated pharmacologically than to continue to have asthma symptoms and exacerbations. According to the Asthma and Pregnancy Working Group (A...
متن کاملAnti igE thErApy in AllErgic AsthmA And AllErgic rhinitis
The last few decades have seen a rise in the prevalence of allergic diseases, including asthma and allergic rhinitis. The prevalence asthma is estimated to be around 300 million globally and around 35% in Europe and Australasia and 60 million people in the United States are affected by rhinitis. In India prevalence asthma is estimated to be around 2.38% and 20% to 26% people suffer from allergi...
متن کاملBiologic targeted therapy in allergic asthma.
OBJECTIVE To review the structure, function, clinical utility, and safety of current biologic targeted therapies being used for the treatment of asthma. DATA SOURCES Medical literature obtained from PubMed and OVID searches from June to November 2013. STUDY SELECTIONS Studies were selected based on article impact, relevance, and clinical significance. Particular emphasis was placed on artic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Immunotherapy
سال: 2018
ISSN: 1750-743X,1750-7448
DOI: 10.2217/imt-2017-0142